The Chemours Company (CC)

The Chemours Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	5,837	5,782	6,078	6,831	6,345	4,969
Revenue Growth (YoY)	0.03%	-4.87%	-11.02%	7.66%	27.69%	-10.08%
Cost of Revenue	4,813	4,631	4,772	5,215	4,964	3,902
Gross Profit	1,024	1,151	1,306	1,616	1,381	1,067
Selling, General & Admin	577	602	526	705	583	526
Research & Development	107	109	108	118	107	93
Other Operating Expenses	-	-	-	-	-	1
Operating Expenses	684	711	634	823	690	620
Operating Income	340	440	672	793	691	447
Interest Expense	-269	-264	-208	-163	-185	-210
Earnings From Equity Investments	36	43	45	55	43	23
Currency Exchange Gain (Loss)	-10	-9	-38	-15	3	-26
Other Non Operating Income (Expenses)	20	14	23	57	36	38
EBT Excluding Unusual Items	117	224	494	727	588	272
Merger & Restructuring Charges	-67	-60	-153	-16	-6	-32
Impairment of Goodwill	-	-56	-	-	-	-
Gain (Loss) on Sale of Assets	5	-	106	23	115	8
Asset Writedown	-	-	-	-	-	-10
Legal Settlements	-263	-	-764	-	-	-37
Other Unusual Items	-1	-1	-1	7	-21	-22
Pretax Income	-189	127	-318	741	676	179
Income Tax Expense	130	41	-81	163	68	-40
Earnings From Continuing Operations	-319	86	-237	578	608	219
Minority Interest in Earnings	-1	-	-1	-	-	-
Net Income	-320	86	-238	578	608	219
Net Income to Common	-320	86	-238	578	608	219
Net Income Growth	-	-	-	-4.93%	177.63%	-
Shares Outstanding (Basic)	150	149	149	155	165	165
Shares Outstanding (Diluted)	150	150	149	158	169	166
Shares Change (YoY)	0.18%	0.85%	-5.93%	-6.16%	1.41%	0.93%
EPS (Basic)	-2.13	0.58	-1.60	3.72	3.69	1.33
EPS (Diluted)	-2.13	0.57	-1.60	3.65	3.60	1.32
EPS Growth	-	-	-	1.39%	172.73%	-
Free Cash Flow	-12	-993	186	448	537	540
Free Cash Flow Per Share	-0.08	-6.61	1.25	2.83	3.18	3.25
Dividend Per Share	0.675	1.000	1.000	1.000	1.000	1.000
Dividend Growth	-32.50%	-	-	-	-	-
Gross Margin	17.54%	19.91%	21.49%	23.66%	21.77%	21.47%
Operating Margin	5.83%	7.61%	11.06%	11.61%	10.89%	9.00%
Profit Margin	-5.48%	1.49%	-3.92%	8.46%	9.58%	4.41%
Free Cash Flow Margin	-0.21%	-17.17%	3.06%	6.56%	8.46%	10.87%
EBITDA	659	741	979	1,084	1,008	767
EBITDA Margin	11.29%	12.82%	16.11%	15.87%	15.89%	15.44%
D&A For EBITDA	319	301	307	291	317	320
EBIT	340	440	672	793	691	447
EBIT Margin	5.83%	7.61%	11.06%	11.61%	10.89%	9.00%
Effective Tax Rate	-	32.28%	-	22.00%	10.06%	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q